Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates. We, at NIRAMAI, have developed a novel artificial intelligence-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable breast cancer screening tool that can be deployed in any primary clinic, hospital or used for outreach programs. The core technology of our solution has been developed using our patented AI / machine learning algorithms for reliable and accurate detection of breast cancer.
Our thermal scanning based Breast Cancer Screening is radiation-free and non-invasive, requiring no incisions
During Breast Cancer Screening, nobody sees or touches you, and the procedure is completely painless
Our AI- based clinically validated Breast Cancer Screening offers best-in-class sensitivity and specificity, that is non-inferior to traditional methods.
The cost of the equipment as well as operating expense is 10-20% of traditional screening methods
The portable equipment can be used to conduct screening camps in rural areas and corporate offices.
Niramai Test works for women aged 18 to 80+ years. It does not depend upon the age or breast density.
Niramai has multiple products for Breast Cancer Screening.
What is Thermalytix Thermalytix is a Novel Artificial Intelligence based medical device for detecting early stage breast cancer. It is an affordable, portable, safe and accurate method of detecting breast abnormalities. It is radiation free, employs no…
Read More
Niramai SMILE-100 System: FDA-Cleared Thermal Imaging for Breast Health The SMILE-100 System is US FDA cleared test that helps a healthcare personnel to review, measure and analyze thermally significant indications in the breast region. It can be…
Read MoreWhat is Mythri Thermalytix? It is a mobile based breast health screening device powered by Thermalytix. It is a low-cost device for breast cancer triaging and risk assessment that can be used for screening in primary health…
Read More
Thermalytix by Niramai is a game-changer — offering a safe, radiation-free, and AI-powered approach to early breast cancer detection. It's making preventive care more accessible, especially for women who need it the most.
Niramai is revolutionizing breast cancer screening with its AI-driven thermal imaging test —offering a groundbreaking, non-invasive, and highly accurate solution that enhances early detection, affordability, and accessibility.
Niramai has great opportunities to improve women’s lives and health around the world, using technology and AI.
Thermography can detect breast cancer in ways that are non-invasive, non-ionizing and non-traumatizing. In addition to detecting tumor growth earlier, this innovation can bring breast cancer screening to the doorsteps of women all over the world. I am happy to partner with Niramai on this journey.
I congratulate Team Niramai for developing an innovative thermal analytics based Breast Cancer Solution for early stage breast cancer detection. This Non-Invasive Risk Assessment with Machine Intelligence, cancer screening solution is relevant for women of all ages and poses minimal health hazard since it is contact and radiation free. I believe Niramai will enable easy adoption for early cancer screening and will play a key role in improving outcomes in our ongoing battle against breast cancer. I am delighted to support this initiative.
First runner up in the mega startup challenge
Niramai won the PHC Tech Challenge award conducted by PATH, CCAMP, et al
Winner of Common wealth Digital Health Award in 2022
Selected for UMASS M2D2 Program 2022
Selected for Marico Innovation Foundation Scale-Up program and tagged as Pride of India
Niramai was awarded Aegis Graham Bell Award 2018 under Innovative Mobile App for Consumer
Winner of Amazon AI Conclave 2017 Award in Health Care
Niramai is among 4 startups from India that got selected for Google Launchpad Accelerator Program 2018
NIRAMAI in Tech30 – Top 30 innovations in 2017
Selected in nasscom 10k startups.
Niramai has received multiple international awards and has recognized to be a pioneer of the new breast cancer screening technology by reputed institutions.
